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ABSTRACT  
Venlafaxine is an antidepressant belonging to a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). 
Venlafaxine affects chemicals in the brain that may be unbalanced in people with depression. It is used to treat major depressive disorder, 
anxiety and panic disorder. The present review assesses the various approaches for analysis of Venlafaxine in bulk drug as well as various 
formulations. A concise review represents the compilation and discussion of about more than 35 analytical methods which includes HPLC, 
HPTLC, UPLC, LC-MS and UV-Spectrophotometry methods implemented for investigation of Venlafaxine in biological matrices, bulk samples 
and in different dosage formulations. This detailed review will be of great help to the researcher who is working on Venlafaxine. 
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Abbreviations: 
VEN: Venlafaxine 
API: Active pharmaceutical ingredients 
pKa: Dissociation constant 
Log P: Partition co-efficient 
HPLC: High performance liquid chromatography 
RP-HPLC: Reverse phase-high performance liquid 
chromatography 
HPTLC: High performance thin layer chromatography 
UPLC-MS: Ultra-performance liquid chromatography-mass 
spectrometry 
UPLC-TMS: Ultra-performance liquid chromatography-
tandem mass spectrometry 
LC-MS: Liquid chromatography-mass spectrometry 
PDA: Photodiode array 
TLC: Thin layer chromatography 
F254: Fluorescence indicator 
ICH: International conference on harmonization 
SIM: Stability indicating method 
 
 
 
Introduction 
Depression is excessive general and disabling disease with 
important social and economic outcome, most of anti-
depressant agents are accessible in management of disorder, 
they are limitations of efficacy, because of toxic effects can be 
encountered. Most harmful effects found to risk for life 
threatening arrhythmias, particularly in patients with early 
survive cardiac disease or after overdose direction. Because 
depression and nervousness disorders are related with acute 
and prevalent psychosocial and occupational disfunction, 
significant reason of abnormality associated with chronic 
disease like, rheumatoid arthritis, hypertension and 
diabetes.[1] 
It was referred to as a Serotonin nor-epinephrine dopamine 
reuptake inhibitor. Venlafaxine HCl was available in market 
name of Effexor tablets. [2] 
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Figure 1. Structure of Venlafaxine HCl 
In investigative examination endeavor originate a novel, 
reproducible and efficient HPLC technique with isocratic 
elution for assurance of venlafaxine in pharmaceutical 
formulations. These technique created was approved and 
utilized for the examination of venlafaxine HCl in cases and 
tablets.[3] Which are work in completed results of venlafaxine 
HCl our best information, venlafaxine isn't accessible in any 
pharmacopeia and no technique for assurance of pollutions 
has been singular strategies either in mass medications or 
pharmaceuticals, accordingly best potential for advancement 
of logical techniques to analyze the degrees of 
contaminations in completed results of venlafaxine during 
the procedure of improvement. [4] 
Table no.1: Drug Profile of Venlafaxine HCl : 
Drug Name Venlafaxine HCl 
Category Anti-depressant 
Chemical formula C17H27NO2 
IUPAC Name 1-[2-(dimethylamino)-1-(4-
methoxyphenyl)ethyl] cyclohexane-1-ol 
Molecular weight 277.402 
Melting point 215-217 
Solubility Freely soluble: Water, Methanol 
BCS Class Class-I (High solubility and high 
permeability) 
Half life 5 hours 
pKa value Strongestacid-14.42, Strongest base- 
8.91 
log P value LogP 2.69, LogP 2.74 
log S value -3.1 
CAS No. 93413-69-5 
 
Venlafaxine HCl side effects: 
Common venlafaxine side effects may include: 
 Mood or behavior changes 
 Anxiety 
 Panic attacks 
 Trouble sleeping 
 Feel impulsive, irritable, agitated, aggressive, restless 
 Nausea, vomiting, diarrhea 
 Dry mouth 
 Dizziness, headache, feeling nervous 
 Fast heartbeats, vision changes 
 Decreased sex drive, or difficulty having an organism. 
Serious side effects: 
 Attempting suicide 
 Acting on dangerous impulses 
 Thoughts about suicide or dying 
 New or worsened depression 
 New or worsened anxiety or panic attacks 
Therapeutic uses of Venlafaxine HCl: 
 Treatment of diabetic neuropathy 
 Effectiveness of migraine prophylaxis 
 Treatment of prostate cancer 
 Action on both serotoninergic and adrenergic systems 
 Reduce episodes of cataplexy 
 Improve patient mood and energy level 
 Help restore patient interest in daily living. 
Analytical techniques used for determination of 
Venlafaxine HCl: 
A.High-performance liquid chromatography (HPLC): 
HPLC is a propelled fluid chromatography utilized in 
isolating the combine blend of particles experienced in 
substance and organic structure. In year 1980, HPLC 
technique originate for first time examine of mass 
medications materials (USP,1980). The essential pieces of a 
HPLC are a solvent (A) Pump (B) Injector (C) Segment (D) 
Detector/Recorder. Each segments are associated in an 
arrangement to one another by steel tubing. The pump 
controls the progression of solvent through the system. Upon 
leaving the pump, solvent enters the injector, at that point 
goes through the section, lastly through the optical unit of a 
detector. [5] The partition of a compound includes its physical 
cooperation with a stationary stage and a portable stage. In 
HPLC the stationary stage is incredibly little. A standard 
molecule size for column chromatography is 60 microns, 
while that for HPLC is ordinarily 5 microns, or the size of a 
spot of residue solvent course through such thick material 
requires a high weight, so in HPLC the stationary stage is 
stuffed in a hardened steel cylinder, and solvent is pumped 
through the framework under high weight, as much as a few 
thousand pounds for every square inch. This weight brings 
about a stream pace of a few ml's per minute.[6] It broadly 
use detectors in HPLC is UV-detectors is equipped for inspect 
a few wavelengths is conceivable to applying the various 
wavelength in examining program. UV-detector surety all the 
UV-engage parts are identified. 
The photodiode cluster (PDA) detector is likewise utilized in 
HPLC instrument. Most delicate detector among the LC 
detector is fluorescence detector. A photodiode cluster (PDA) 
is a lined exhibit of discrete photodiodes on a coordinated 
circuit (IC) chip for spectroscopy. It is put at the picture 
plane of a spectrometer to enable a scope of wavelengths to 
be detected simultaneously. [5]  
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Table no.2: HPLC method for venlafaxine HCl: 
Sr. 
no. 
Drug Method Stationary phase Mobile phase Detection Linearity, LOD, LOQ 
(µg/mL) 
Rt / FR 
 
 
Ref 
1 Venlafaxine 
HCl 
HPLC C18(150×4.6mm, 
5µm) Coupled to 
Guard column C18 
(30×4.6mm, 5µm) 
Acetonitrile, 
Potassium 
phosphate buffer 
(pH6.5) 
(30:20v/v) 
228 nm 
UV-visible 
detection 
Linearity:                   
1.05-10.5µg/mL      
LOD:--                         
LOQ: -- 
Rt:15.2 min 
Fr:1 mL/min 
7 
2 Venlafaxine  
HCl 
RP-
HPLC 
ODS-C18 
(50×4.6mm, 5µm) 
Acetonitrile, 
Sodium acetate 
(65:35 v/v) 
225 nm Linearity:                     
2.0-50.0µg/mL         
LOD:--                          
LOQ: -- 
Rt:2.83 min 
Fr: 1 mL/min 
8 
3 Venlafaxine  
HCl 
HPLC ODS RP-C18 
(4.6×150mm,5µm) 
Acetonitrile, 
Water(70:30v/v) 
230nm Linearity:                          
9 μg – 2  µg/mL   
LOD:1.3µg/mL 
LOQ:1.10 µg/mL 
Rt: 4.8 min 
Fr: 1.5mL/min 
9 
4 Venlafaxine  
HCl 
RP-
HPLC 
Microsorb MV 100 
C18 
(250×4.6mm,5µm) 
Acetonitrile, 0.04 
potassium 
dihydrogen 
phosphate, 
Methanol 
(45:25:30 v/v) 
224 nm Linearity:       
1-50 µg/mL 
LOD: 0.568µg/mL 
LOQ: 1.72 µg/mL 
Rt:3.43 min 
Fr:1 mL/min 
3 
5 Venlafaxine  
HCl , Modafinil 
RP-
HPLC 
C18 
(4.6×250mm,5µm) 
Ammonium 
acetate buffer 
(pH4.0), 10% 
Methanol in 
acetonitrile 
(60:40) 
225 nm Linearity:    
1.0-50 µg/mL 
LOD: -- 
LOQ: -- 
Rt:    Venlafaxine 
4.4min  
Modafinil-       6.4 
min 
Fr:1mL/min 
10 
6 
 
 
 
Venlafaxine 
HCl 
HPLC- 
MS/MS 
Varomycin chiral 
column 
(250×4.6mm,5µm) 
Methanol, 
Ammonium 
acetate(8:92 
v/v) 
224 nm Linearity:  
0.28-423.0 µg/mL 
LOD:0.02 µg/mL 
LOQ:0.28 µg/mL 
Rt:  
6.72 min 
Fr:  
1 mL/min 
11 
7 Esomeprazole, 
Venlafaxine  
HCl 
Fenofibrate 
HPLC C18 (150×4.6mm, 
3.5µm) 
A-Acetonitrile, 
buffer(25:75v/v)  
B-Acetonitrile, 
buffer(30:70v/v) 
 
230 nm Linearity:                
10.37-518.40µg/mL  
Esomeprazole 
LOD:1.02µg/mL         
LOQ: 5.18 µg/mL 
Venlafaxine HCl      
LOD:1.02µg/mL 
LOQ:5.09 µg/mL 
Fenofibrate  
LOD:1.05µg/mL          
LOQ:5.22 µg/mL 
Esomeprazole 
Rt:3.25min               
Fr: 1.1 mL/min 
 
Venlafaxine HCl 
Rt:4.7min            
Fr:1.1 mL/min 
Fenofibrate   
Rt:13.12min        
Fr: 1.1mL/min 
12 
8 Venlafaxine  
HCl,           o-
desmethyl 
venlafaxine 
HPLC C18 (25×4.6mm) Methanol, 
Acetonitrile 
(95:5v/v) and 
40%Ammonium 
acetate 
235 nm Venlafaxine HCl 
Linearity range:            
1-20µg/mL    
LOD:0.2µg/mL     
LOQ:0.5 µg/mL 
O-desmethyl Ven. HCl   
Linearity range:            
1-25µg/mL   
LOD:0.3µg/mL      
LOQ:1.0µg/mL 
Venlafaxine  HCl 
Rt: 7.2 min 
Fr: 0.7mL/min. 
O-desmethyl Ven. 
HCl 
Rt:4.9min         Fr: 
0.7 mL/min 
6 
9 Venlafaxine  
HCl 
RP-
HPLC 
Kromasil KR100-5 
C18(4.6×250mm, 
5µm) 
Diethylamine 
buffer, Methanol 
(90:10 v/v) 
225nm 
PDA 
detection 
Linearity:                     
0.5-5.0µg/mL 
LOD:0.095µg/mL    
LOQ: 0.29 µg/mL 
Rt: 5 min 
Fr:1mL/min 
13 
10 Venlafaxine  
HCl 
RP-
HPLC 
C18Isocratic 
column(250×4.6mm, 
5µm) 
Acetonitrile, 
Water(50:50v/v) 
226 nm Linearity:                        
1-5µg/mL  
LOD:0.0665µg/mL    
LOQ:0.199 µg/mL 
Rt: 3.5 min 
Fr: 1.0mL/min 
14 
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B. UV- visible spectrophotometric method: 
UV-visible spectroscopy is examining the wavelength of 
typical sample. The UV-visible spectra have expensive 
highlights are restricted use for test identification are helpful 
for quantitative estimations. Spectrophotometric method is 
most significant technique is recognize the substance 
element on premise of transmission or reflection properties 
of material as capacity of wavelength, adheres to the Beer-
Lambert's law and synthetic compound which bear a 
chromophoric bunch for retention of light, it consume the 
less time when contrasted with other technique and gives 
incredible accuracy in practical.[15] The writing overview 
educate the UV techniques and RP-HPLC strategy are 
accounted for the assurance of venlafaxine HCl exclusively 
with different medications present examination includes 
improvement and approval of new UV-spectroscopy 
technique for assurance of venlafaxine HCl in unadulterated 
and its pharmaceutical plans suggest economical conditions. 
The investigative strategy was approved by ICH guidelines 
approval parameters. [16] 
Distilled water was researched to build up a reasonable UV-
visible spectrophotometric technique for the investigation of 
Venlafaxine hydrochloride in details. For choice of media the 
criteria utilized were affectability of the technique, simplicity 
of test planning, dissolvability of the medication, and cost of 
solvents and appropriateness of strategy to different 
purposes. [17] 
 
Table no.3: UV- Spectrometric Method for Venlafaxine HCl : 
Sr. 
No. 
Drug Matrix Method Solvent Detectio
n 
Linearity/LOD, LOQ Ref. 
1 Venlafaxine HCl Bulk and 
Formulation 
UV-visible 
spectrophotometric 
method (JascoV-630) 
0.1N 
NaOH 
223 nm Linearity:                                      
5-25µg/mL                     
R2:0.996            
LOD:0.95µg/mL                   
LOQ: 0.29µg/mL 
18
2 Venlafaxine HCl Bulk and 
Formulation 
Double beam perkin 
Elmer UV-visible 
spectrophotometer 
(Model Labda 25) 
Water 225 nm Linearity:                                     
4-24µg/mL                   
R2:0.9991                              
LOD:--                                      
LOQ: -- 
17
3 Venlafaxine HCl API ELICO SL-210 double 
beam UV-visible 
spectrophotometer 
Water 225 nm Linearity:                                     
2-24µg/mL                     
R2:0.999          
LOD:0.955µg/mL 
LOQ:2.895µg/mL 
19
4 Venlafaxine HCl Bulk and 
Formulation 
UV-visible 
spectrophotometer model 
117 with resolution of 0.1 
nm 
Phosphat
e buffer 
(pH6.8) 
222 nm Linearity:                                     
2-26µg/mL                       
R2:0.9999                              
LOD:--                                     
LOQ: -- 
20
5 Venlafaxine HCl Capsule dosage 
form 
UV 1601 series 
(Shimadzu), UV-visible 
double beam 
spectrophotometer 
Water 274 nm Linearity:                                   
50-250µg/mL              
R2:0.9998                                
LOD:--                                       
LOQ: -- 
21
6 Venlafaxine HCl Bulk and Tablet 
form 
Systronics UV-visible 
spectrophotometer 
Model-2203 
Water 626 nm Linearity:                                  
10-50µg/mL                  
R2:0.9995                              
LOD:--                                     
LOQ:-- 
22 
7 Venlafaxine HCl Bulk and 
Formulation 
UV- spectrometry Water 225 nm Linearity:                                   
50-160µg/mL             
R2:0.9995         
LOD:0.29µg/mL 
LOQ:1.01µg/mL 
23
 
 
 C. High performance thin layer chromatography 
(HPTLC): 
Planar Chromatography instead of column chromatography 
(for example GC, HPLC) uses a level (planar) stationary stage 
for detachment. In Thin-Layer Chromatography (TLC) this 
stationary stage is support by magnifier sheets or a foil 
(plastic or aluminum). Again dissimilar to section partitions, 
of TLC plate comprises an open framework, which goes 
entire individual strides of TLC investigation in a 
disconnected mode. HPTLC is a most adaptable strategy and 
is known for consistency, immaculateness profile, measure 
and exactness and precision of results. It can deal with a few 
examples of even dissimilar nature and structure. Synthetic 
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inspection is necessary section in enabling a research center 
to guarantee routine satisfying enforcement execution of 
scientific strategies. Arrangement and put resources into 
stages to a ultra-modern completely programmed HPTLC 
slope System with different identifiers. Perceivability of the 
example all through the chromatographic examination i.e., 
after example application and chromatograph 
advancement.[24] The HPTLC framework (Camag, Muttenz, 
Switzerland) furnished with an example implement 
Linomat-V associated with a nitrogen chamber, twin trough 
plate advancement chamber (10×10cm), TLC Camag Scanner 
III and Wincats-4.02 pre-covered silica gel 60 F254 TLC 
aluminum plates.[25] Most labs use TLC/HPTLC for 
investigation, test, or examination with comparable 
examples, screening of unclear examples or large number of 
samples. Quality control, logical R&D, process observing, and 
ecological labs discover TLC/HPTLC as a valuable 
instrument for standard investigation. [26]
 
Table no.4: HPTLC Method for Venlafaxine HCl : 
Sr. 
no. 
Drug and 
Matrix 
Stationary 
phase 
Mobile 
phase 
Chamber 
saturation/ TLC 
plate 
development 
time 
Detection Linearity, LOD, 
LOQ 
(µg/mL) 
Ref.  
1 Venlafaxine  
HCl  (Bulk, 
Capsule 
formulation) 
Precoated Silica 
gel 60 F254 
(10×10cm, 
0.2mm 
Thickness) TLC 
plate 
 
Methanol, 
Ammonia 
(4.5:0.5 v/v) 
CSt: 25min 
PDt: 20min 
Rf value: 0.65 
Densitometry 
scanning at 
224nm 
Linearity:     
500-3000 
µg/mL 
R2: 0.998 
LOD: 7.7µg/mL 
LOQ: 23.3µg/mL 
25 
2 Venlafaxine  
HCl (API and 
pharmaceutical 
dosage form) 
Precoated Silica 
gel 60 F254 on 
Aluminium 
sheets 
(10×10cm, 
0.2mm 
Thickness) TLC 
plate 
 
Toluene, 
Methanol 
(4:6 v/v) 
CSt: 25min 
PDt: 20min 
Rf value: 0.47 
Densitometry 
scanning at 
230nm 
Linearity:         
2-7µg/mL 
R2: 0.996 
LOD: 0.17µg/mL 
LOQ: 0.53µg/mL 
27 
3 Venlafaxine  
HCl  (Bulk, 
Tablets) 
(10×20cm) 
Aluminium 
backed HPTLC 
plates coated 
with 0.2mm 
layer of Silica gel 
60 F254 
 
Toluene, 
Methanol 
(7:3.5 v/v) 
CSt: 10min 
PDt: 20min 
Rf value: 0.19 
Densitometry 
scanning at 
228nm 
Linearity:     
400-2000µg/mL 
R2: 0.999 
LOD: 
97.12µg/mL 
LOQ: 
294.30µg/mL 
28 
 
 
D. Stability indicating method: 
Singh and Bakshi discussed some conclusive points of 
developing SIM. [29] Dolan suggests the comments on SIA. [30] 
Smela discussed regulatory points about SIM is analytical 
method.[31] SIM procedure is used to measure the diminution 
the quantity of API in drug substances prefer degradation 
studies. SIM may also check stability of drug matter and 
products changes in separate time intervals of study. These 
method accurately estimate the changes API concentrations 
in the absence of impurities, excipients and other 
degradation products. 
Stress testing is done to demonstrate specificity of the 
created method to quantify the adjustments in grouping of 
substance when little data is accessible about prospective 
degradation product. The improvement of reasonable 
stability indicating method provides a background for 
preformulation thinks about, stability examines and improve 
the proper storage condition. [32]  
These ICH guidelines are relevant to forced degradation 
study: 
 ICH Q1 A: Stability testing of new drug substance and 
products.[33] 
 ICH Q1 B: Photostability testing of new drug substance 
and products.[34] 
 ICH Q2 B: Validation of analytical procedure, 
methodology.[35] 
Solution state stability: 
1. Acidic hydrolysis 
2. Alkaline hydrolysis 
3. Hydrolytic 
4. Oxidative degradation 
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Solid state solubility: 
1. Thermal degradation 
2. Photolytic degradation 
 
 
 
 
 
Table no.5: Stress Testing: (forced degradation) : 
Degradation factor Condition 
Thermal ≥ 600C 
Humidity ≥ 75% RH 
Acid 0.1N HCL 
Base 0.1N NaOH 
Oxidative Oxygen gas, 3% H2O2 
Photolytic Metal halide, Hg, Xe lamp, 
UV-B fluorescent 
Table no.6: Stability indicating method for venlafaxine HCl: 
Sr. 
No. 
Method Drug R.T&R.T of 
Degradation 
Product/Development 
Time Rf value of drug 
Column/ 
Stationary 
phase 
Mobile Phase & Flow 
Rate, Chamber 
saturation time 
Wavelength, 
Linearity, 
Coefficient 
correlation. 
LOQ & LOD 
(µg/mL) 
Ref 
1 HPLC Venlafaxine  HCl  
(Extended release) 
Run time- 15min 
Retention time- 
4.49min 
 
(5µm, 
250×4.6mm) 
Kromacil 
C18 column 
Phosphate buffer 
(pH4.5), Methanol 
(40:60) 
Flow rate- 1mL/min 
UV-detection 
225 nm 
Linear 
range- 
42-78µg/mL 
R2=0.9997 
LOD- 
0.075µg/mL 
LOQ- 0.15 
µg/mL 
36 
2 HPLC Venlafaxine  HCl  
(Sustained release 
tablet) 
Run time- 10min 
Retention time- 7.6min 
 
(5µm, 
250×4.6mm) 
RP inertsil 
ODS-3V C18 
column 
Phosphate buffer, 
Acetonitrile (80:20) 
Flow rate- 0.8ml/min 
UV-detection 
225 nm 
Linear 
range- 
0.1-5 µg/mL 
R2=0.9999 
LOD- 0.26  
µg/mL 
LOQ- 
0.81µg/mL 
37 
3 LC O-
Desmethylvenlafaxine 
(API) 
Run time- 14min 
Retention time- __ 
 
(3µm, 
150×4.6mm) 
YMC-pack 
ODS-A 
column 
A) Buffer, Acetonitrile 
(85:15 v/v) 
B) Water, Acetonitrile 
(20:80 v/v) 
Flow rate-1ml/min 
230 nm 
Linear 
range-20-
160 µg/mL 
R2=0.9996 
LOD- 0.04 
µg/mL 
LOQ- 0.13 
µg/mL 
38 
4 LC Venlafaxine HCl Run time- 10min 
Retention time- 
4.32min 
 
(5µm, 
4.6×250mm) 
Spherisorb 
C8 column 
Acetonitrile, Sodium 
dihydrogen 
orthophosphate(pH6.8) 
(75:25) 
Flow rate – 1.5ml/min 
224 nm 
Linear 
range-1-10 
µg/mL 
R2=0.9999 
LOD- 150  
µg/mL 
LOQ- 
600µg/mL 
39 
5 LC Venlafaxine  HCl  
(Extended release 
capsule) 
Run time- 10min 
Retention time- 6.8min 
 
(5µm, 
250×4.6mm) 
luna C18 
column 
Phosphoric acid, 
Acetonitrile, Methanol 
(62:30:8) 
Flow rate- 1ml/min 
226 nm PDA 
detector 
Linear 
range- 10-
70µg/mL 
R2=0.9999 
LOD-0.24 
µg/mL 
LOQ-0.80 
µg/mL 
40 
6 HPTLC Venlafaxine  HCl 
(Bulk & dosage form) 
TLC Pate Development 
time – 20min 
Rf value- 0.46±0.05 
(10×10cm, 
2mm 
thickness) 
Aluminium 
plates 
precoated 
silica gel 60 
F254 
Dichloromethane, 
Acetonitrile, N-Hexane, 
Triethylamine 
(0.5:0.5:4:0.7) 
Saturation time- 15min 
Camag TLC 
scanner-3 
225 nm 
Linear 
range-100-
1000µg/mL 
R2=0.9918 
LOD- 
12.48µg/mL 
LOQ- 
37.81µg/mL 
41 
7 HPTLC Venlafaxine  HCl TLC plate Development 
time- 25min 
Rf value- 0.58±0.02 
(10×10cm, 
2mm) 
HPTLC plate 
coated with 
0.25mm 
layer of 
silica gel 60 
F254 plates 
Butanol, Acetic acid, 
Water (6:2:2) 
Saturation time- 20min 
Reflectance 
scanning 
camag TLC 
scanner-3 
225 nm 
Linear 
range-100-
600µg/mL 
R2=0.9984 
LOD- 
39.23µg/mL 
LOQ- 
130.89µg/mL 
42 
 
E. Bio-analytical method: 
These bioanalytical validation technique established by 
Karnes et al. in 1991which was intentional to give direction 
to bioanalytical chemists. After one year, Shah et al. 
established these report the convention on Analytical 
technique validation of bioavailability, bioequivalence and 
pharmacokinetic studies organized in Washington in 1990. 
[43] 
Bio-analytical method promotes the quantitative analytical 
technique appropriate biochemical approach. HPLC, RP-
HPLC, HPLC-MS/ESI, UPLC-MS, UPLC-TMS, LC and GC 
combined with mass spectroscopic procedure, LC-MS, LC-
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MS/MS. Bioanalysis is innovative technique for improve the 
accuracy, precision, efficiency, sensitivity, specificity, assays, 
data handling, processes, analysis cost, data quality. [44] 
 
Table no.7: Bioanalytical method for venlafaxine HCl : 
Sr. 
No
. 
Metho
d 
Drug Bio. 
Fluid 
Column Mobile 
Phase 
Flow Rate 
& 
Retention 
Time 
Detection/D
etector 
Linearity & 
LOD&LOQ 
Re
f.  
1 RP-
HPLC 
Venlafaxine and O-
desmethyl 
Huma
n 
Plasm
a 
(4.6×150mm,5µ
m) Spherisorb S5 
C18 column 
Acetonitri
le, 
Phosphate 
buffer 
(30:70v/v
) 
Flow rate- 
1.4mL/mi
n 
Retention 
time- 
8min 
UV-Detector 
and Datajet 
integrator at 
229nm 
Linearity:           
0.2-0.5µg/mL  
LOD:--                
LOQ: -- 
45 
2 RP-
HPLC 
Venlafaxine  HCl Huma
n 
Plasm
a 
(150×4.6mm,5µ
m) Alltima C8 
column 
0.1% O-
phosphori
c acid, 
Methanol 
(50:50 
v/v) 
Flow rate-
0.7mL/mi
n 
Retention 
time- 
7min 
___ Linearity:                
2-25µg/mL     
LOD-
2.00µg/mL 
LOQ-
5.00µg/mL 
27 
3 HPLC-
ESI/M
S 
Venlafaxine and O-
desmethylvenlafax
ine enantiomers 
Huma
n 
Plasm
a 
(250×4.6mm,5µ
m) Vancomycin 
chiral column 
Ammoniu
m acetate, 
Methanol 
(15:85v/v
) 
Flow rate- 
1mL/min 
VEN  
Retention 
time- 
11.8min 
ODV 
 Retention 
time- 
11.2min 
Ionized in the 
positive 
electrospray 
ionization ion 
source of the 
mass 
spectroscopy 
Linearity: - 
VEN:                     
5.0-400µg/mL 
LOD1.0µg/mL 
LOQ-5.0µg/mL 
ODV:                     
4.0-300µg/mL  
LOD-1.5µg/mL  
LOQ-4.3µg/mL 
47 
4 HPLC-
MS/ES
I 
Venlafaxine and 
its three 
metabolites 
Huma
n 
Plasm
a 
(250×4.6mm,5µ
m) Thermo BDS 
hypersil C18 
column 
Water, 
Acetonitri
le (60:40 
v/v) 
Flow rate- 
1mL/min 
VEN  
Retention 
time- 
4.43min 
ODV 
Retention 
time-3.01 
min 
NDV 
Retention 
time- 
3.95min 
DDV 
Retention 
time- 
2.88min 
Ionized in 
electrospray 
ionization ion 
source of 
mass 
spectrometer 
detected in 
selected ion 
recording 
VEN           
Linearity:            
4.0-700µg/mL     
LOD-0.4µg/mL 
LOQ- 3.5µg/Ml 
ODV          
Linearity:           
2.0-900µg/mL     
LOD-0.2µg/mL  
LOQ-2.2µg/mL 
NDV          
Linearity:            
3.0-800µg/mL     
LOD-0.3µg/mL 
LOQ-2.7µg/mL 
DDV          
Linearity:           
2.0-700µg/mL     
LOD-0.2µg/mL 
LOQ-1.9µg/mL 
48 
5 UPLC-
TMS 
Venlafaxine and O-
desmethylvenlafax
ine 
Huma
n 
Plasm
a 
(50×2.1mm, 
1.7µm) Acquity 
UPLCBEH C18 
column 
Methanol, 
Ammoniu
m acetate 
(85:15 
v/v) 
Flow rate- 
0.30mL/m
in 
Retention 
time-    3 
min 
Triple 
quadrupole 
tandem mass 
spectrometer 
(TMS) via 
electrospray 
ionization 
source (ESI) 
Linearity:  
0.200-
200µg/mL 
LOD-
0.10µg/mL 
LOQ-
0.200µg/mL 
49 
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Conclusion  
The present review illustrates various analytical approaches 
exercised for the estimation of Venlafaxine. A numerous 
investigation had perform including, Bio-analytical, Stability 
indicating, HPLC, HPTLC, UV-Visible Spectroscopy, and LC-MS, 
etc. for estimation of Venlafaxine in bulk and in its combined 
pharmaceutical formulations and in plasma. Liquid 
chromatography with UV detection has been found to be most 
studied for estimation of ven. in bulk as well as pharmaceutical 
dosage forms, while hyphenated such as LC-MS methods are 
reported for determination of Venlafaxine and its metabolite in 
plasma and other biological fluids. Few chromatography 
approaches like HPTLC and UV Spectrophotometry methods 
are also used for assay of Venlafaxine.  
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